ArticleThe Lancet regional health. Europe2024

Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination.

David Hodgson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.